(MedPage Today) — Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the RANK ligand inhibitor can be challenging to navigate.
“I don’t think we have all the answers yet of the…
Source link : https://www.medpagetoday.com/spotlight/aace-osteoporosis/116198
Author :
Publish date : 2025-06-23 17:29:00
Copyright for syndicated content belongs to the linked Source.
